What makes us different from one another? Why does one person jump out of airplanes for fun while another prefers to stay home and read? Why are some babies born with a predisposition to become anxious? Questions about individual differences in temperament have engaged the minds of scientists, psychologists, and philosophers for centuries. Recent technological advances in neuroimaging and genetics provide an unprecedented opportunity to answer these questions. Here we review the literature on the neurobiology of one of the most basic individual differences-the tendency to approach or avoid novelty. This trait, called inhibited temperament, is innate, heritable, and observed across species. Importantly, inhibited temperament also confers risk for psychiatric disease. Here, we provide a comprehensive review of inhibited temperament, including neuroimaging and genetic studies in human and non-human primates. We conducted a meta-analysis of neuroimaging findings in inhibited humans that points to alterations in a fronto-limbic-basal ganglia circuit; these findings provide the basis of a model of inhibited temperament neurocircuitry. Lesion and neuroimaging studies in non-human primate models of inhibited temperament highlight roles for the amygdala, hippocampus, orbitofrontal cortex, and dorsal prefrontal cortex. Genetic studies highlight a role for genes that regulate neurotransmitter function, such as the serotonin transporter polymorphisms (5-HTTLPR), as well as genes that regulate stress response, such as corticotropin-releasing hormone (CRH). Together these studies provide a foundation of knowledge about the genetic and neural substrates of this most basic of temperament traits. Future studies using novel imaging methods and genetic approaches promise to expand upon these biological bases of inhibited temperament and inform our understanding of risk for psychiatric disease.
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Abbreviations: 5-HTTLPR, serotonin transporter-linked polymorphic region; A1AR, adenosine A 1A receptor gene; A2AR, adenosine A 2A receptor gene; ACC, anterior cingulate cortex; ACTH, adrenocorticotropic hormone; ADHD, attention-deficit hyperactivity disorder; ALE, activation likelihood estimation; ALN, alone in a new cage condition in the human intruder paradigm; BNST, bed nucleus of the stria terminalis; CeA, central nucleus of the amygdala; COMT, catechol-O-methyltransferase gene; CRH, corticotropinreleasing hormone; CRH, corticotropin-releasing hormone gene; CRHR1, corticotropin-releasing hormone receptor 1 gene; CNTNAP2, contactin-associated protein-like 2; DAT, dopamine transporter gene; dlPFC, dorsolateral prefrontal cortex; dmPFC, dorsomedial prefrontal cortex; DRD4, dopamine D4 receptor gene; EEG, electroencephalography; ERN, error-related negativity; ERP, event-related potential; FDG, [
18 F]-fluorodeoxyglucose; fMRI, functional magnetic resonance imaging; GABA, gamma-aminobutyric acid; GAD, glutamic acid decarboxylase gene; GWAS, genome-wide association study; HPA, hypothalamic-pituitary-adrenal axis; MAOA, monoamine oxidase A gene; MMN, mismatch negativity; MRI, magnetic resonance imaging; mRNA, messenger RNA; NEC, no eye contact condition in the human intruder paradigm; NPY, neuropeptide Y; NPY1R, neuropeptide Y receptor 1; NPY5R, neuropeptide Y receptor 5; NTRK3, neurotrophic tyrosine kinase receptor, type 3; OFC, orbitofrontal cortex; PET, positron emission tomography; PFC, prefrontal cortex; PENK, preproenkephalin gene; RGS2, regulator of G protein signaling 2; SERT, serotonin transporter gene; SNP, single nucleotide polymorphism; ST, stare condition in the human intruder paradigm.
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